RECURSION PHARMACEUTICALS, INC. (RXRX) Net income 2019–2025
RECURSION PHARMACEUTICALS, INC. (RXRX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$644.8MFY2025 · since FY2019: -$61.9M → -$644.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$644.8M | -39.1% |
| FY2024 | -$463.7M | -41.3% |
| FY2023 | -$328.1M | -37.0% |
| FY2022 | -$239.5M | -28.4% |
| FY2021 | -$186.5M | -114.3% |
| FY2020 | -$87.0M | -40.6% |
| FY2019 | -$61.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice